Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Dual-target Neurofeedback Therapy for Internet Gaming Disorder

Official title: Mechanistic Study on Brain-Computer Interface-Based Dual-Target Neurofeedback Training Intervention for Cognitive Control Deficits in Internet Gaming Disorder

Run by The First Affiliated Hospital of Bengbu Medical University · NCT07843615 · Data updated 2026-11-12

We test a dual-target neurofeedback approach to see if it helps improve cognitive control in young adults with Internet Gaming Disorder.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment120 (estimated)
SponsorThe First Affiliated Hospital of Bengbu Medical University
Academic / other
Locations1 site (Bengbu)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 30, 2028
Study endsDecember 30, 2028
Registry record updatedSeptember 28, 2026
Trial IDNCT07843615 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-35 with Internet Gaming Disorder, high gaming time, and a GDSS score of 47 or higher who are right-handed and able to participate in follow-up assessments.

Probably not a fit

Individuals not meeting the criteria or with severe comorbid conditions, left-handedness, or significant cognitive impairment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests a combined neurofeedback system that both activates neural circuits involved in cognitive control and reinforces social rewards, aiming to improve self-regulation in IGD. Participants undergo different neurofeedback conditions, including a dual-target intervention, a neural-only intervention, and sham feedback. The study focuses on 18- to 35-year-olds with high gaming engagement and confirmed IGD symptoms, following standardized criteria. Outcomes likely include measures of cognitive control, gaming behavior, and engagement with the intervention over time. The research addresses neural mechanisms, intervention targets, and strategies to sustain participation beyond initial treatment phases.

Why it matters

Potential benefit: If successful, patients may experience better impulse control and reduced gaming, improving daily functioning and quality of life.

How similar studies have gone: Prior research suggests neurofeedback can modulate cognitive control networks, but combining social reward mechanisms with neural targets is a relatively novel approach with limited prior success data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals aged between 18 and 35 years, irrespective of gender, having completed a minimum of 9 years of education and capable of effectively cooperating in questionnaire evaluations
* Consent to actively cooperate in the completion of subsequent follow-up assessments
* Right-handed
* The Gaming Disorder Screening (GDSS) Scale score ≥ 47 points
* Average weekly gaming time greater than 21 hours, maintained for over one year
* More than 50% of daily internet time spent playing online games

Exclusion Criteria:

* Severe cognitive functional impairments manifested through a history of head trauma, cerebrovascular diseases, epilepsy, etc., or usage of cognitive enhancement drugs in the past 6 months
* Left-handed
* An intellectual disability with an IQ score less than 70
* A diagnosis of schizophrenia or other severe mental illnesses as per the DSM-5 criteria
* Abuse or dependence on other psychoactive substances (excluding nicotine) within the past 5 years
* Severe organic diseases that might compromise study participation
* Color blindness or color weakness

Where it's running

  • Bengbu Medical University
    Bengbu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.